For how we live.
A registry analysis of Abyan Governorate from 2020 to 2024 puts numbers on a vaccine-preventable disease that returned as immunisation coverage fell — with the heaviest toll among children aged 5 to 9.
An analysis of a decade of surveillance data shows the system leans heavily on hospitals and misses cases in the community — the weakness that lets measles circulate undetected between outbreaks.
A systematic review of the Syrian crisis and infectious disease in Lebanon names overcrowding, poor sanitation and blocked healthcare access — not the presence of refugees themselves — as the reported drivers.
WHO reports 19,161 suspected cases and 166 deaths in a single month, most in children under five. The country had been close to eliminating the disease.
The objection turns on a no-treatment arm. WHO says placebo or no-treatment vaccine trials are acceptable only where no proven intervention exists, and here one does.
The year-end immunization summary reports 88% fewer measles deaths since 2000, malaria vaccine in 24 African countries, and 25 years without wild polio in the Western Pacific.
WHO has graded the regional resurgence a level 2 emergency. Only 5.7% of the 20,412 suspected cases were laboratory-confirmed, and the antitoxin that prevents most deaths is in global short supply.
A Global Burden of Disease analysis of 204 countries finds 15.7 million children received no DTP dose in 2023, more than half of them in eight countries, and only one of three target vaccines on track for 2030.
A Federal Register notice on 9 June listed eleven vaccine topics and ten scheduled votes over three days. An amended notice on 24 June listed seven topics, three votes and two days.